SCHEMBL29473245

SCHEMBL29473245

O=C(Nc1cc(Br)ccc1O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
HTT P42858 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
LMNA P02545 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MGLL Q99685 1/20 0.50
MAOB P27338 1/20 0.50
PTPN1 P18031 1/20 0.49
POLB P06746 1/20 0.49
ENPP2 Q13822 2/20 0.48
PTGES O14684 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MAOA P21397 1/20 0.46
PLAU P00749 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8247251 0.85 NPC1 (0.55) NPC1RAB9AHTTL3MBTL1LMNA
SCHEMBL29473232 0.84 LRRK2 (0.54) NPC1RAB9AHTTL3MBTL1LMNA
SCHEMBL29473230 0.84 LRRK2 (0.54) NPC1RAB9AHTTL3MBTL1LMNA
SCHEMBL16193637 0.83 ALOX15 (0.61) NPC1RAB9AL3MBTL1LMNAMGLL
SCHEMBL14648942 0.82 NPC1 (0.70) NPC1RAB9AHTTL3MBTL1LMNA
SCHEMBL16193532 0.82 NPC1 (0.69) NPC1RAB9AHTTLMNAMGLL
SCHEMBL30522295 0.82 NPC1 (0.69) NPC1RAB9AHTTLMNAMGLL
SCHEMBL16609975 0.81 HTT (0.54) NPC1RAB9AHTTL3MBTL1LMNA
SCHEMBL15330140 0.81 NPC1 (0.53) NPC1RAB9AHTTMGLLMAOB
SCHEMBL14648946 0.81 HTT (0.57) NPC1RAB9AHTTL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229062-A1 BICYCLIC COMPOUNDS Aligos Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081758-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed